The Chinese manufacturer of a widely used blood pressure medication said it had launched a global recall after US and European regulators warned of contamination by a cancer-causing impurity.
Wednesday, 18 July 2018
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment